Location History:
- Brussels, BE (2012 - 2018)
- Princeton, NJ (US) (2018)
Company Filing History:
Years Active: 2012-2018
Title: The Innovative Contributions of Sabine Maier
Introduction
Sabine Maier is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of medical research, particularly in the area of cell proliferative disorders. With a total of 5 patents to her name, her work has the potential to impact treatment outcomes for patients undergoing anthracycline therapy.
Latest Patents
One of her latest patents is focused on "Markers for the prediction of outcome of anthracycline treatment." This invention relates to methods for predicting the effectiveness of anthracycline treatment in patients with cell proliferative disorders. It involves determining the expression levels of specific genes, including PITX2, TFF1, and PLAU. Additionally, she has developed methods and nucleic acids for the analysis of colon cell proliferative disorders. This patent provides innovative techniques for detecting and differentiating between various colon disorders by analyzing genes such as Versican, TPEF, H-Cadherin, Calcitonin, and EYA4.
Career Highlights
Throughout her career, Sabine has worked with notable companies, including Epigenomics AG and Therawis Diagnostics GmbH. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.
Collaborations
Some of her notable coworkers include Ralf Lesche and John Foekens. Their collaborative efforts have contributed to the advancement of research in the field of cell proliferative disorders.
Conclusion
Sabine Maier's innovative work and patents reflect her dedication to improving patient outcomes in medical treatments. Her contributions to the field are invaluable and continue to inspire future research and development.